Synthetic Dermal Regenerative Substitute Development

The contract seeks the research, design, and development of fully synthetic or biosynthetic skin substitutes designed to enable dermal regeneration without relying on donor tissue. The goal is to create innovative, scalable solutions that replicate or enhance the structural and functional properties of natural skin, with a focus on promoting healing, minimizing immune rejection, and supporting long-term tissue integration. This effort is intended to advance medical countermeasures for burn victims, chronic wound patients, and other trauma-related conditions requiring rapid and effective dermal repair. Awarded as a subcontract under the Department of Health and Human Services’ Aspr Administration for Strategic Preparedness and Response, the project is governed by NAICS code 339113, indicating classification within medical device manufacturing. The opportunity was posted on July 28, 2026, with a response deadline of August 28, 2026, and the place of performance is designated as 77416. The initiative aligns with national preparedness objectives to secure advanced medical technologies that reduce dependence on human tissue sources, increase availability, and ensure readiness for large-scale public health emergencies involving skin loss or damage.